:

How long has denosumab been on the market?

Denosumab first received U.S. Food and Drug Administration (FDA) approval for its osteoporosis brand name, Prolia, on June 1, 2010. Since then, denosumab has also been approved under the brand name Xgeva for oncology-related indications, with its first approval coming later in 2010.